The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
It’s the Law: Enantiomer Exclusivity Revisited: The Food and Drug Administration Amendments Act of 2007
Posted 01 February 2008 | By
Tucked away at the end of the Food and Drug Administration Amendments Act of 2007 (FDAAA) is a provision that modifies FDA's longstanding refusal to award five-year new chemical entity (NCE) exclusivity to enantiomers of previously approved racemic mixtures.1